-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Questions for stem cell transplant in peripheral T-cell non-Hodgkins lymphomas
Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
Instruments that measure the quality of life in atopic dermatitis among children and adolescents
Claudia Soido Falcao do Amaral, Maria de Fatima Bazhuni Pombo March, Clemax Couto SantAnna
Clinical Trail Methodology: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation